Lv71
5000 积分 2020-12-30 加入
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension
18天前
已完结
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy
26天前
已关闭
Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
1个月前
已完结
Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
2个月前
已关闭
NON–RESPONSE TO INCLISIRAN THERAPY IN THREE PATIENTS WITH STATIN INTOLERANCE: A CASE SERIES
3个月前
已关闭
恶性周围神经鞘瘤靶向治疗的研究进展
3个月前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
3个月前
已完结
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD
4个月前
已关闭
[Chinese guidelines for lipid management (2023)]
4个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
